| Authors: |
Stackowicz J; Unit of Antibodies in Therapy and Pathology, Department of Immunology, Institut Pasteur, Paris, 75015, France.; INSERM U1222, Paris, France.; Université Pierre et Marie Curie, Paris, 75252, France.; Department of Biology, École Normale Supérieure Paris-Saclay, 94230, Cachan, France., Balbino B; Unit of Antibodies in Therapy and Pathology, Department of Immunology, Institut Pasteur, Paris, 75015, France.; INSERM U1222, Paris, France.; Université Pierre et Marie Curie, Paris, 75252, France., Todorova B; Unit of Antibodies in Therapy and Pathology, Department of Immunology, Institut Pasteur, Paris, 75015, France.; INSERM U1222, Paris, France., Godon O; Unit of Antibodies in Therapy and Pathology, Department of Immunology, Institut Pasteur, Paris, 75015, France.; INSERM U1222, Paris, France., Iannascoli B; Unit of Antibodies in Therapy and Pathology, Department of Immunology, Institut Pasteur, Paris, 75015, France.; INSERM U1222, Paris, France., Jönsson F; Unit of Antibodies in Therapy and Pathology, Department of Immunology, Institut Pasteur, Paris, 75015, France.; INSERM U1222, Paris, France., Bruhns P; Unit of Antibodies in Therapy and Pathology, Department of Immunology, Institut Pasteur, Paris, 75015, France.; INSERM U1222, Paris, France., Reber LL; Unit of Antibodies in Therapy and Pathology, Department of Immunology, Institut Pasteur, Paris, 75015, France. laurent.reber@inserm.fr.; INSERM U1222, Paris, France. laurent.reber@inserm.fr. |
